Submitted by Anonymous (not verified) on 25 August 2023 - 15:18
Opinion/decision on a Paediatric investigation plan (PIP): Recombinant human monoclonal antibody to GM-CSF (GSK3196165), decision type: , therapeutic area: , PIP number: P/0266/2020
Source: